EUVIMEDEUVIMED entdecken
Crossref

Digoxin attenuates bisphosphonate related osteonecrosis of the jaws by RORγt-dependent Th17 response in male rats

José Vitor Mota Lemos, Joyce Ohana de Lima Martins, Larissa Carvalho Machado, Lara Rabelo Aragão, Maria Elisa Quezado Lima Verde, Cláudia do Ó Pessoa, Maria Júlia Barbosa Bezerra, Ana Paula Negreiros Nunes Alves, Paulo Goberlânio de Barros Silva

Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology · 2024-12 · 138 (6) · 781-793

DOI: 10.1016/j.oooo.2024.08.013 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, 2024-12. Verfasst von José Vitor Mota Lemos und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Dentistry, Division of Oral Pathology, School of Pharmacy, Dentistry and Nursing, Universidade Federal do Ceará, Fortaleza, Ce…. Hauptthemen laut MEDLINE: Digoxin, Rats, Wistar, Th17 Cells, Bisphosphonate-Associated Osteonecrosis of the Jaw. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: CNPq.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: The study aimed to evaluate digoxin, an RORγt inhibitor, in Medication-Related Osteonecrosis of the Jaws (MRONJ) in male rats treated with zoledronic acid (ZA). STUDY DESIGN: Forty male Wistar rats were divided into a negative control group (0.1 mL/kg saline), a positive control group (ZA, 0.20 mg/kg), and three test groups treated with ZA and digoxin at 1 (DG1), 2 (DG2), or 4 (DG4) mg/kg. These groups received treatment three times weekly. ZA was administered intravenously on days 0, 7, and 14, followed by extraction of the left lower first molar on day 42, a final ZA dose on day 49, and euthanasia on day 70. Analyses included radiographic, histomorphometric, and immunohistochemical evaluation of the mandibles, western blotting of gingiva, and mechanical tests on femurs. Statistical analysis was performed using ANOVA/Bonferroni tests (P < .05). RESULTS: Digoxin reduced radiolucency of MRONJ (P < .001), inflammatory cells, empty osteocyte lacunae (P < .001), apoptotic osteoclasts (P < .001), and Caspase-3-positive osteocytes (P = .021). ZA increased immunoreactivity for most markers except c-Fos, while digoxin reduced interleukin 17, TNF-α, IL-6, IL-2, FOXP3, c-Jun, NFκB (P < .001), TGF-β (P = .009), RANKL (P = .035), and OPG (P = .034). Digoxin also reversed RORγt expression (P < .001), increased diarrhea scores (P = .028), renal and cardiac indexes (P < .001), and enhanced femur mechanical properties (P < .013). CONCLUSIONS: Digoxin attenuated MRONJ by inhibiting RORγt and reducing the Th17 response.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DigoxinRats, WistarTh17 CellsBisphosphonate-Associated Osteonecrosis of the JawZoledronic AcidNuclear Receptor Subfamily 1, Group F, Member 3DiphosphonatesAnimalsMaleRatsImidazolesBlotting, WesternImmunohistochemistryBone Density Conservation AgentsDisease Models, Animal

Substanzen

DigoxinZoledronic AcidNuclear Receptor Subfamily 1, Group F, Member 3DiphosphonatesImidazolesBone Density Conservation Agents

Autor:innen und Institutionen

  • Department of Clinical Dentistry, Division of Oral Pathology, School of Pharmacy, Dentistry and Nursing, Universidade Federal do Ceará, Fortaleza, Ceará, Brazil.
  • Department of Dentistry, Laboratory of Oral Pathology, Unichristus, Fortaleza, Ceará, Brazil.
  • Department of Physiology and Pharmacology at the Federal University of Ceará, Fortaleza, Ceará, Brazil.
  • Department and Laboratory of Molecular Biology and Genetics of the Instituto do Câncer do Ceará, Fortaleza, Ceará, Brazil.
  • Department of Dentistry, Laboratory of Oral Pathology, Unichristus, Fortaleza, Ceará, Brazil; Department of Clinical Dentistry, Division of Oral Pathology, School of Pharmacy, Dentistry and Nursing, Universidade Federal…

Förderung

  • CNPq

Zitieren

APA

Lemos, J. V. M., Martins, J. O. L., Machado, L. C., Aragão, L. R., Verde, M. E. Q. L., Pessoa, C. D. Ó., Bezerra, M. J. B., Alves, A. P. N. N., & de Barros Silva, P. G. (2024). Digoxin attenuates bisphosphonate related osteonecrosis of the jaws by RORγt-dependent Th17 response in male rats. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, 138(6), 781-793. https://doi.org/10.1016/j.oooo.2024.08.013

Vancouver

Lemos JVM, Martins JOL, Machado LC, Aragão LR, Verde MEQL, Pessoa CDÓ, et al. Digoxin attenuates bisphosphonate related osteonecrosis of the jaws by RORγt-dependent Th17 response in male rats. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology. 2024;138(6):781-793. doi:10.1016/j.oooo.2024.08.013

BibTeX
@article{Lemos2024,
  author = {Lemos, José Vitor Mota and Martins, Joyce Ohana de Lima and Machado, Larissa Carvalho and Aragão, Lara Rabelo and Verde, Maria Elisa Quezado Lima and Pessoa, Cláudia do Ó and Bezerra, Maria Júlia Barbosa and Alves, Ana Paula Negreiros Nunes and de Barros Silva, Paulo Goberlânio},
  title = {Digoxin attenuates bisphosphonate related osteonecrosis of the jaws by RORγt-dependent Th17 response in male rats},
  journal = {Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology},
  year = {2024},
  volume = {138},
  number = {6},
  pages = {781--793},
  doi = {10.1016/j.oooo.2024.08.013}
}
Kostenlos starten →